These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 23500524

  • 41. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells.
    Promkan M, Liu G, Patmasiriwat P, Chakrabarty S.
    Int J Cancer; 2009 Dec 15; 125(12):2820-8. PubMed ID: 19551867
    [Abstract] [Full Text] [Related]

  • 42. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin.
    Wang S, Huang X, Lee CK, Liu B.
    Oncogene; 2010 Jul 22; 29(29):4225-36. PubMed ID: 20498641
    [Abstract] [Full Text] [Related]

  • 43. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
    Liu Y, Lu WL, Guo J, Du J, Li T, Wu JW, Wang GL, Wang JC, Zhang X, Zhang Q.
    J Control Release; 2008 Jul 02; 129(1):18-25. PubMed ID: 18466993
    [Abstract] [Full Text] [Related]

  • 44. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
    Hsu EC, Kulp SK, Huang HL, Tu HJ, Salunke SB, Sullivan NJ, Sun D, Wicha MS, Shapiro CL, Chen CS.
    Neoplasia; 2015 Jun 02; 17(6):497-508. PubMed ID: 26152358
    [Abstract] [Full Text] [Related]

  • 45. TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer.
    Bhola NE, Balko JM, Dugger TC, Kuba MG, Sánchez V, Sanders M, Stanford J, Cook RS, Arteaga CL.
    J Clin Invest; 2013 Mar 02; 123(3):1348-58. PubMed ID: 23391723
    [Abstract] [Full Text] [Related]

  • 46. Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo.
    Chen SY, Hu SS, Dong Q, Cai JX, Zhang WP, Sun JY, Wang TT, Xie J, He HR, Xing JF, Lu J, Dong YL.
    Asian Pac J Cancer Prev; 2013 Mar 02; 14(10):6135-40. PubMed ID: 24289639
    [Abstract] [Full Text] [Related]

  • 47. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
    Ahmadipour F, Noordin MI, Mohan S, Arya A, Paydar M, Looi CY, Keong YS, Siyamak EN, Fani S, Firoozi M, Yong CL, Sukari MA, Kamalidehghan B.
    Drug Des Devel Ther; 2015 Mar 02; 9():1193-208. PubMed ID: 25759564
    [Abstract] [Full Text] [Related]

  • 48. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
    Tang X, Li X, Li Z, Liu Y, Yao L, Song S, Yang H, Li C.
    Tumour Biol; 2016 Oct 02; 37(10):13425-13433. PubMed ID: 27460092
    [Abstract] [Full Text] [Related]

  • 49. Knockdown of cyclophilin A reverses paclitaxel resistance in human endometrial cancer cells via suppression of MAPK kinase pathways.
    Li Z, Min W, Gou J.
    Cancer Chemother Pharmacol; 2013 Nov 02; 72(5):1001-11. PubMed ID: 24036847
    [Abstract] [Full Text] [Related]

  • 50. Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway.
    Lai TC, Fang CY, Jan YH, Hsieh HL, Yang YF, Liu CY, Chang PM, Hsiao M.
    Cell Commun Signal; 2020 Oct 21; 18(1):164. PubMed ID: 33087151
    [Abstract] [Full Text] [Related]

  • 51. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
    Zhang HD, Sun DW, Mao L, Zhang J, Jiang LH, Li J, Wu Y, Ji H, Chen W, Wang J, Ma R, Cao HX, Wu JZ, Tang JH.
    Biochem Biophys Res Commun; 2015 Oct 02; 465(4):702-13. PubMed ID: 26299922
    [Abstract] [Full Text] [Related]

  • 52. An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells.
    Jia D, Li L, Andrew S, Allan D, Li X, Lee J, Ji G, Yao Z, Gadde S, Figeys D, Wang L.
    Cell Death Dis; 2017 Jul 13; 8(7):e2932. PubMed ID: 28703802
    [Abstract] [Full Text] [Related]

  • 53. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
    Li SY, Sun R, Wang HX, Shen S, Liu Y, Du XJ, Zhu YH, Jun W.
    J Control Release; 2015 May 10; 205():7-14. PubMed ID: 25445694
    [Abstract] [Full Text] [Related]

  • 54. The Hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24-/low subpopulation and the side population of breast cancer cells.
    Tanaka H, Nakamura M, Kameda C, Kubo M, Sato N, Kuroki S, Tanaka M, Katano M.
    Anticancer Res; 2009 Jun 10; 29(6):2147-57. PubMed ID: 19528475
    [Abstract] [Full Text] [Related]

  • 55. Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.
    Xiang F, Ni Z, Zhan Y, Kong Q, Xu J, Jiang J, Wu R, Kang X.
    Tumour Biol; 2016 May 10; 37(5):6017-25. PubMed ID: 26596839
    [Abstract] [Full Text] [Related]

  • 56. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
    Huang ZJ, You J, Luo WY, Chen BS, Feng QZ, Wu BL, Jiang L, Luo Q.
    Mol Med Rep; 2015 Mar 10; 11(3):1647-54. PubMed ID: 25405855
    [Abstract] [Full Text] [Related]

  • 57. Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts.
    Cufi S, Corominas-Faja B, Vazquez-Martin A, Oliveras-Ferraros C, Dorca J, Bosch-Barrera J, Martin-Castillo B, Menendez JA.
    Oncotarget; 2012 Apr 10; 3(4):395-8. PubMed ID: 22565037
    [Abstract] [Full Text] [Related]

  • 58. Inhibition of Notch1 increases paclitaxel sensitivity to human breast cancer.
    Zhao L, Ma Y, Gu F, Fu L.
    Chin Med J (Engl); 2014 Apr 10; 127(3):442-7. PubMed ID: 24451948
    [Abstract] [Full Text] [Related]

  • 59. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.
    Jagadish N, Fatima R, Sharma A, Devi S, Suri V, Kumar V, Suri A.
    Tumour Biol; 2018 May 10; 40(5):1010428318773652. PubMed ID: 29745297
    [Abstract] [Full Text] [Related]

  • 60. Adenovirus adenine nucleotide translocator-2 shRNA effectively induces apoptosis and enhances chemosensitivity by the down-regulation of ABCG2 in breast cancer stem-like cells.
    Jang JY, Kim MK, Jeon YK, Joung YK, Park KD, Kim CW.
    Exp Mol Med; 2012 Apr 30; 44(4):251-9. PubMed ID: 22198296
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.